Skip to main content

TV C75 (Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg)

Pill with imprint TV C75 is Blue, Capsule-shape and has been identified as Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Emtricitabine/tenofovir is used in the treatment of pre-exposure prophylaxis; occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Emtricitabine/tenofovir 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TV C75

Emtricitabine and tenofovir disoproxil fumarate 200 mg / 300 mg TV C75

Emtricitabine and Tenofovir Disoproxil Fumarate

TV C75
200 mg / 300 mg
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.